Overall rank by patents
#3,952
of 49,997 tracked assignees
USPTO PatentsView assignee record - 91 granted patents across 13 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).
The verdict
According to USPTO PatentsView, Abiomed ranks #3,952 of 49,997 tracked US assignees by granted-patent volume, with 91 patents across 13 technology areas.
USPTO PatentsView assignee plate
Corpus R3952 · Foreign Corporation #3,952 · 91 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Agios Pharmaceuticals, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Bundesdruckerei · near
52 score
Woodstream · near
52 score
Abiomed Europe · this assignee
52 score
NEC Laboratories… · near
52 score
Panasonic Liquid… · near
52 score
3D Lighting… · lowest
7 score
What this shows Abiomed's Innovation Score is 52.5/100 (top 10% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Abiomed Europe GmbH is a focused PatentsView assignee: 13 CPC subclasses with 95.6% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2023 (17 grants) versus a trough of 1 in 2019. By volume, Abiomed sits between Veeco Instruments Inc. and Board of Trustees of Southern Illinois University.
From 2019–2021 to 2022–2024, Abiomed Europe GmbH moved from 21 to 41 grants (1.95x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Veeco Instruments Inc.
92 patents
Videojet Technologies Inc.
92 patents
Watts Regulator Co.
92 patents
Willis Electric Co., Ltd.
92 patents
Agios Pharmaceuticals, Inc.
91 patents
Anhui Huami Information Technology Co., Ltd.
91 patents
Azur Space Solar Power GmbH
91 patents
Board of Trustees of Southern Illinois University
91 patents
Abiomed Europe GmbH
91 patents
What this shows Abiomed holds 91 patents at rank #3,952, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,952 in granted patent volume.
Other assignees with the most granted patents in Abiomed's primary technology class.
Two PlainPatent-derived peer sets for Abiomed, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (52 here).
Nearest assignees by average claims per patent (18.4 here).
Abiomed's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
52 Top 10% higher than 90% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 3 | 3.3% |
| 2017 | 6 | 6.6% |
| 2018 | 2 | 2.2% |
| 2019 | 1 | 1.1% |
| 2020 | 9 | 9.9% |
| 2021 | 11 | 12.1% |
| 2022 | 9 | 9.9% |
| 2023 | 17 | 18.7% |
| 2024 | 15 | 16.5% |
| 2025partial year | 18 | 19.8% |
Top 13 of 13 technology areas
Overall rank by patents
#3,952
of 49,997 tracked assignees
52.5 out of 100
What to do with this data
Abiomed Europe GmbH's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.